Dr. Manish Sharma, MD
Claim this profileSTART Midwest
Studies Solid Tumors
Studies Cancer
15 reported clinical trials
27 drugs studied
Area of expertise
1Solid Tumors
Stage IV
Stage III
ER positive
2Cancer
Stage IV
Stage III
PD-L1 positive
Affiliated Hospitals
Clinical Trials Manish Sharma, MD is currently running
CLN-619 + Pembrolizumab
for Cancer
This trial is testing a new drug called CLN-619 alone and with pembrolizumab in patients with advanced solid tumors. These patients may not have other treatment options. Pembrolizumab helps the immune system fight cancer, and they are seeing if CLN-619 can help too.
Recruiting1 award Phase 110 criteria
TROP2 ADC
for Cancer
A Phase I-II, First-in-Human Study of SKB264 in Patients with Locally Advanced Unresectable/Metastatic Solid Tumors who are refractory to Available Standard Therapies. Patient must have historically documented, incurable, locally advanced or metastatic cancer that are refractory to standard therapies of one of the following types: 1. Triple negative breast cancer 2. Epithelial ovarian cancer 3. Non-small cell lung cancer 4. Gastric adenocarcinoma/Gastroesophageal junction adenocarcinoma 5. Small cell lung cancer 6. HR+/ HER2-breast cancer 7. Head and neck squamous cell carcinoma 8. Endometrial carcinoma 9. Urothelial carcinoma
Recruiting1 award Phase 1 & 213 criteria
More about Manish Sharma, MD
Clinical Trial Related5 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Manish Sharma, MD has experience with
- Pembrolizumab
- Nivolumab
- BMS-986258
- BMS-986442
- Paclitaxel
- Docetaxel
Breakdown of trials Manish Sharma, MD has run
Solid Tumors
Non-Small Cell Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Manish Sharma, MD specialize in?
Manish Sharma, MD focuses on Solid Tumors and Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Manish Sharma, MD currently recruiting for clinical trials?
Yes, Manish Sharma, MD is currently recruiting for 6 clinical trials in Grand Rapids Michigan. If you're interested in participating, you should apply.
Are there any treatments that Manish Sharma, MD has studied deeply?
Yes, Manish Sharma, MD has studied treatments such as Pembrolizumab, Nivolumab, BMS-986258.
What is the best way to schedule an appointment with Manish Sharma, MD?
Apply for one of the trials that Manish Sharma, MD is conducting.
What is the office address of Manish Sharma, MD?
The office of Manish Sharma, MD is located at: START Midwest, Grand Rapids, Michigan 49546 United States. This is the address for their practice at the START Midwest.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.